First Lyme Disease Vaccine Shows 73% Success in Trials

A groundbreaking Lyme disease vaccine has proven 73% effective in major trials, bringing hope to millions at risk from tick-borne illness.

After decades without protection, regulatory approval could arrive soon for people ages five and up.